High levels of β-D-Glucan in immunocompromised children with proven invasive fungal disease

Alessandra Mularoni, Elisa Furfaro, Maura Faraci, Alessia Franceschi, Paola Mezzano, Roberto Bandettini, Claudio Viscoli, Elio Castagnola

Research output: Contribution to journalArticle

Abstract

The plasmatic levels of 1,3-β-D-glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.

Original languageEnglish
Pages (from-to)882-883
Number of pages2
JournalClinical and Vaccine Immunology
Volume17
Issue number5
DOIs
Publication statusPublished - May 2010

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'High levels of β-D-Glucan in immunocompromised children with proven invasive fungal disease'. Together they form a unique fingerprint.

  • Cite this